Asston Pharmaceuticals Ltd — Important, 04-09-2026: Company Update

The company has announced a board meeting on October 26. The key agenda for this meeting is to review and approve the financial results for the quarter and half-year. This is a crucial update for investors, offering insights into the company's recent operational and financial performance. Additionally, the Board will consider a proposal for a rights issue of equity shares. This potential capital raise could impact the company's capital structure and fund future growth, providing important clarity on funding plans and shareholder opportunities.